文献速递免疫规划慢病防控与筛查

实体器官移植受者接种第二剂SARS-CoV-2疫苗后抗体滴度峰值延迟:前瞻性队列研究

Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study.
PubMed 文献 · Vaccine · 2024-08-24

多中心前瞻性观察研究纳入614例实体器官移植受者(肾460例、心53例、肝50例、肺20例、胰肾联合31例),接种两剂mRNA疫苗后1个月血清阳性率43%,3个月升至68%,6个月70%;肾、肺或胰肾联合移植受者在3个月和6个月时抗体滴度低于其他受者。

要点

  • 第二剂mRNA疫苗接种后1个月血清阳性率43%,3个月68%,6个月70%。
  • 肾、肺或胰肾联合移植受者在3个月和6个月时抗体滴度低于其他受者。
  • 实体器官移植受者SARS-CoV-2 S-IgG抗体产生缓慢,峰值滴度与一般人群显著不同。

核心结论

  • 实体器官移植受者接种第二剂SARS-CoV-2疫苗后抗体产生缓慢,峰值滴度与一般人群显著不同。

研究设计与样本

  • 多中心前瞻性观察研究纳入614例实体器官移植受者:肾移植460例、心脏移植53例、肝移植50例、肺移植20例、胰肾联合移植31例。
  • 参与者按指示接种两剂mRNA疫苗(辉瑞BNT162b2或Moderna mRNA-1273)。
  • 在首剂和第二剂接种前以及第二剂接种后1、3、6个月采集血清样本检测SARS-CoV-2抗体。

主要发现

  • 第二剂疫苗接种后1个月总血清阳性率为43%,3个月逐渐升至68%,6个月升至70%。
  • 肾、肺或胰肾联合移植受者在3个月和6个月时间点的抗体滴度低于其他受者。
  • 实体器官移植受者获得SARS-CoV-2 S-IgG抗体缓慢,峰值滴度与一般人群显著不同。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Poor post-vaccination production of antibody against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a concern among solid organ transplant (SOT) recipients. Furthermore, the timing and kinetics of antibody titers after the second vaccine dose are unknown. We conducted a multicenter prospective observational study that included 614 SOT recipients: 460 kidney, 53 heart, 50 liver, 20 lung, and 31 simultaneous pancreas-kidney (SPK). The participants received two doses of the mRNA vaccine (Pfizer BNT162b2 or Moderna mRNA-1273), as indicated. Serum samples were collected before the first and second vaccinations and at 1, 3, and 6 months after the second vaccine dose, which were then assessed for SARS-CoV-2 antibodies. The overall seropositivity rate was 43% at 1 month after administration of the second vaccine dose; it gradually increased to 68% at 3 months after second dose administration and to 70% at 6 months. In addition, recipient of kidney, lung or SPK transplants had lower antibody titers at the 3- and 6-month time points than did the other recipients. SOT recipients acquired SARS-CoV-2 S-IgG antibodies slowly, and the peak titer differed significantly from that of the general population.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Unagami K, Yoshikawa M, Egawa H, et al. Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study. Vaccine. 2024. PMID: 39180977. doi:10.1016/j.vaccine.2024.126221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。